Many Canadians hold positive views of clinical trials and are willing to participate in research, according to a new study.
The paper, published recently in Therapeutic Innovation & Regulatory Science, is based on a survey of more than 1,600 British Columbia and Ontario residents who provided their views on the benefits and risks of clinical research participation. Almost 70 percent of respondents indicated willingness to participate in a clinical trial, and nearly 60 percent expressed positive views towards clinical research.
In addition to indicating strong overall support for clinical trials, the study highlights the importance of awareness and education. The finding that 43 percent of respondents felt either not very informed or not at all informed about clinical trials suggests a need to provide more information to the public about clinical trial participation.
The survey findings are highly relevant to Can-SOLVE CKD’s efforts to increase public participation in health research. As we move forward in 2019 with a new vision for the Canadian Nephrology Trials Network and the creation of a portal for connecting patients to research opportunities, this information will help inform effective strategies for engaging more Canadians in kidney health research.
Can-SOLVE CKD Network Executive Director Heather Harris is a co-author of the study.